Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 4
1(16.7%)
6Total
N/A(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06694259Not ApplicableRecruiting

Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy

Role: lead

NCT04755972Not ApplicableCompleted

Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2

Role: lead

NCT01550679Completed

Early Detection of COPD Patients in GOLD 0 (Smokers) Population

Role: collaborator

NCT04445779Not ApplicableUnknown

Q10 Preloading Before Cardiac Surgery for Kidney Failure Reduction

Role: lead

NCT03013595Not ApplicableUnknown

The MILESTONE Study: Improving Transition From Child to Adult Mental Health Care

Role: collaborator

NCT01694212Not ApplicableCompleted

Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy

Role: collaborator

NCT02767713Phase 4Unknown

Cognitive Dysfunction Following Cardiac Surgery

Role: lead

NCT00805428Unknown

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

Role: lead

All 8 trials loaded